US 11299490
Benzenesulfonamide compounds and their use as therapeutic agents
granted A61PA61P25/08A61P3/12
Quick answer
US patent 11299490 (Benzenesulfonamide compounds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P25/08, A61P3/12